Skip to main content
. 2021 Jan 22;105(3-4):181–191. doi: 10.1159/000511245

Table 5.

Group 1: patients with local therapy in the retroperitoneum

Histology Stage Therapy Recurrence rate (%) Occurrence of recurrence
Seminoma I 20 Gy 3–5 Years 1–3
Seminoma IIA 30 Gy 5–10 Years 1–4
Seminoma IIB 36 Gy 10–15 Years 1–4
Non-seminomatous GCT IIA/B 3× PEB + RTR 2–5 Years 1–3
Non-seminomatous GCT IIC/III (good prognosis) 3× PEB + RTR 11–18 Years 1–4